The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival for patients with pre-treated platinum-resistant ovarian cancer receiving gotistobart in combination with pembrolizumab.
 
Joyce Barlin
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Corcept Therapeutics; Daiichi Sankyo; Eisai; Genmab; Genmab; Immunogen; MDoutlook; Merck; Mersana; OncoC4; Precision Biosciences; Verastem
Speakers' Bureau - AstraZeneca; Clovis Oncology; Merck
Travel, Accommodations, Expenses - OncoC4
 
Peter Lim
Honoraria - Intuitive Surgical
Speakers' Bureau - Intuitive Surgical
 
Jessica Thomes Pepin
No Relationships to Disclose
 
Elizabeth Hopp
Employment - GE Healthcare (I)
Stock and Other Ownership Interests - GE Healthcare (I)
Consulting or Advisory Role - Immunogen
 
Noelle Cloven
Consulting or Advisory Role - Abbvie; diachi; Genmab; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; GlaxoSmithKline; Merck
 
Helen Eshed
No Relationships to Disclose
 
Destin Black
Stock and Other Ownership Interests - Trials365
Consulting or Advisory Role - GOG Partners; Intuitive Surgical; Merck; Novita Pharmaceuticals; Pfizer
Research Funding - Abbvie (Inst); Acrivon Therapeutics (Inst); AOA Diagnostics (Inst); AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GEICO (Inst); Genmab (Inst); GlaxoSmithKline (Inst); GOG Partners (Inst); Innovis Pharma (Inst); Karyopharm Therapeutics (Inst); KLUS Pharma (Inst); Lilly (Inst); Merck (Inst); Novita Pharmaceuticals (Inst); OncoC4 (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Intuitive Surgical; Merck
Other Relationship - AstraZeneca
 
Hope Cottrill
Stock and Other Ownership Interests - Intuitive Surgical; Lilly; Stryker
Honoraria - Curio Science
Consulting or Advisory Role - Abbvie; AstraZeneca; Cardinal Health; Pfizer
 
Lauren Hand
No Relationships to Disclose
 
David O’Malley
Consulting or Advisory Role - Abbvie; AstraZeneca; Corcept Therapeutics; DualityBio; GlaxoSmithKline; GOG Foundation; Merck; Novocure; Novocure; Pfizer; Regeneron; Sutro Biopharma; Verastem; Zentalis
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie/Stemcentrx (Inst); Acerta Pharma (Inst); Advaxis (Inst); Ajinomoto (Inst); Amgen (Inst); Arcus Biosciences (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BBI Healthcare (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Clovis Oncology (Inst); Deciphera (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Ergomed (Inst); Exelixis (Inst); Genentech/Roche (Inst); Genmab (Inst); GlaxoSmithKline (Inst); Immunogen (Inst); Immunogen (Inst); Incyte (Inst); Iovance Biotherapeutics (Inst); Karyopharm Therapeutics (Inst); Leap Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Mersana (Inst); Novartis (Inst); NovoCure (Inst); OncoQuest (Inst); Pfizer (Inst); Pfizer (Inst); PharmaMar (Inst); Precision Therapeutics (Inst); Regeneron (Inst); Roche (Inst); Sanofi (Inst); SeaGen (Inst); Seagen (Inst); Sumitomo Dainippon Pharma Oncology, Inc. (Inst); Sutro Biopharma (Inst); Tesaro (Inst); Verastem (Inst); Zentalis (Inst)
 
Linus Chuang
No Relationships to Disclose
 
Christine Lee
No Relationships to Disclose
 
Lyndsay Willmott
Consulting or Advisory Role - Corcept Therapeutics; Daiichi Sankyo/Lilly; Gilead Sciences; GlaxoSmithKline; Pfizer
Speakers' Bureau - Abbvie; AstraZeneca; GlaxoSmithKline; Merck; Pfizer
 
Michael Chisamore
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Joan Durbin
Employment - OncoC4
Stock and Other Ownership Interests - GE Healthcare; Gilead Sciences
Patents, Royalties, Other Intellectual Property - I hold 2 patents, both awarded to Rutgers University. One is for a hybrid type I Interferon, the other for a novel RSV vaccine candidate.
Travel, Accommodations, Expenses - OncoC4
 
Pan Zheng
Employment - OncoC4
Leadership - OncoC4
Stock and Other Ownership Interests - OncoC4
Patents, Royalties, Other Intellectual Property - Patent on ONC-392, a new next generation anti-CTLA-4 antibody.
 
Yang Liu
Employment - OncoC4
Leadership - OncoC4
Stock and Other Ownership Interests - OncoC4
 
Andre Overesch
Employment - Affimed Therapeutics; BioNTech
Stock and Other Ownership Interests - Affimed Therapeutics; BioNTech
Patents, Royalties, Other Intellectual Property - Affimed Therapeutics
 
Svetlana Shpyro
Employment - BioNTech
Stock and Other Ownership Interests - BioNTech
 
Bradley Monk
Honoraria - Abbvie; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab; Genmab/Seagen; GlaxoSmithKline; GOG Foundation; Immunogen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Mural; Myriad Genetics; Natera; Novartis; Novocure; Onco4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Consulting or Advisory Role - Abbvie; Alkermes; AstraZeneca; BioNTech SE; Corcept Therapeutics; DSI; Eisai; Genmab/Seattle Genetics; GOG Foundation; Gradalis; ImmunoGen; Incyte; Karyopharm Therapeutics; Lilly; Merck; Mersana; Myriad Pharmaceuticals; Natera; Novartis; Novocure; OncoC4; Panavance Therapeutics; Pharma&; ProfoundBio; Regeneron; Roche/Genentech; Sutro Biopharma; Tubulis GmbH; Verastem; Zentalis; Zymeworks
Speakers' Bureau - AstraZeneca; Eisai; Immunogen/Abbvie; Lilly; Merck; TESARO/GSK
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)